Nordic Nanovector to present at 11th Annual World ADC Europe 2021 Digital
Oslo, March 8, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces that its Chief Scientific Officer, Jostein Dahle, will give a presentation on 9 March at the 11th Annual World ADC Europe 2021 Digital event (8-11 March 2021) in the Discovery stream discussing the question: Should Payloads be Super-Potent?
Presentation details are as follows:
Title: Targeting CD37 with Alpha- & Beta-Emitting Radioimmunoconjugates
Date/time: Tuesday, 9 March 2021 at 11:40am GMT
During his presentation, Dr Dahle with cover the following points:
Review CD37 as target for radioimmunotherapy
Analyse preclinical and clinical data for treatment of Non-Hodgkin's Lymphoma (NHL) with the beta-emitting radioimmunoconjugate 177Lu-lilotomab satetraxetan (Betalutin®)
Evaluate preclinical data for treatment of Chronic Lymphocytic Leukaemia and NHL with the alpha-emitting radioimmunoconjugate 212Pb-TCMC-NNV003 (Alpha37)
World ADC Europe is an industry-leading conference and Europe's largest gathering of ADC stakeholders. It brings together 300 drug developers from 160 active ADC organisations to help forward-thinking researchers from the pharmaceutical, biotech and academic community advance the development of antibody-drug conjugates.
About Nordic Nanovector:
Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting antibody-radionuclide-conjugate designed to advance the treatment of non-Hodgkin's lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 26 billion by 2028. Nordic Nanovector retains global marketing rights to Betalutin® and intends to actively participate in the commercialisation of Betalutin® in the US and other major markets.
Lightware continues delivering the most innovative solutions in USB and USB-C signal management, and will showcase its latest developments for the corporate, education and live event sectors during this year's Infocomm, taking place in Las Vegas in...
Fluence, a global leader in evidence-based psychedelic therapy training, has announced a partnership with Metamorph AI, a pioneering AI technology company, to develop an AI-powered tool to enhance the training of psychedelic therapists.
We believe...
Envera Systems ("Envera" or the "Company"), a leading provider of automated and software-enabled security solutions, announced today the appointment of Dax Brady-Sheehan as President and Chief Executive Officer. Brady-Sheehan succeeds Envera Founder...
Hyundai Motor joins its third straight Advanced Clean Transportation (ACT) Expo to share its hydrogen vision, HTWO, and introduce its U.S. hydrogen commercial vehicle businessAt its press conference, Hyundai Motor shares its U.S. hydrogen commercial...
Today, Booking.com releases new research, with insights gathered from more than 31,000 travellers including 1,000 from Australia, exploring the latest attitudes and priorities related to sustainable travel, revealing:
New data from the company's...
Saviynt, a leading provider of cloud-native identity and governance platform solutions, today announced the appointment of James Ross as RVP-ANZ as the company has seen rapid growth in the Australia and New Zealand (ANZ) region, with double digit...